Lv2
150 积分 2022-05-10 加入
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
3天前
已完结
Trastuzumab induces gastrointestinal side effects in HER2-overexpressing breast cancer patients
1个月前
已完结
P2.10.12 Trastuzumab Deruxtecan in Patients From China With Pretreated HER2-Mutant NSCLC: Final Results From the DESTINY-Lung05 Study
1个月前
已完结
The Association of TSLP and IL-4 with Patient-Reported Outcome Measures in Chronic Rhinosinusitis with Nasal Polyps
1个月前
已完结
Advances in Targeting HER2 across Cancer Subtypes – A Pan-tumor Approach
1个月前
已完结
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy
1个月前
已完结
Targeting HER2 in solid tumors: Unveiling the structure and novel epitopes
2个月前
已完结
CCL3+ neutrophil signature predicts response to neoadjuvant toripalimab plus chemotherapy in patients with hypopharyngeal squamous cell carcinoma: A phase II trial
2个月前
已完结
Hitting the Mark — Individualizing Therapy for HER2-Positive Early-Stage Breast Cancer
2个月前
已完结
Efficacy and safety of neoadjuvant SHR-A1811 with or without pyrotinib in women with locally advanced or early HER2-positive breast cancer: a randomized, open-label, phase II trial
2个月前
已完结
皖公网安备34019202002308
